Tilray Brands Inc is a global leader in the cannabis industry, specializing in the cultivation, production, and distribution of a diverse range of cannabis products. The company operates across various segments, including medical and recreational cannabis, as well as hemp-derived wellness products. Tilray focuses on innovation and quality, offering a portfolio that encompasses various formats such as dried flower, oils, edibles, and beverages. In addition to its core cannabis business, Tilray is dedicated to advancing research, education, and consumer awareness within the rapidly evolving market, positioning itself as a key player in the development and expansion of cannabis-related offerings worldwide. Read More
The cannabis market reacted big time to Trump's re-posting of a pro-CBD video that highlighted CBD’s potential to reduce aging-related ailments and replace costly pharmaceuticals. In addition, Tilray announced significant international expansion.
Stocks shrugged off the government shutdown by hitting record highs; the focus now turns to the upcoming earnings season, which will likely lead stocks higher.
Looking back on beverages, alcohol, and tobacco stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Coca-Cola (NYSE:KO) and its peers.
A number of stocks fell in the afternoon session after signs of weakening consumer health and a cautious outlook for the upcoming holiday season emerged.
Recent results from a national survey conducted by the University of Michigan reveal a sharp rise in cannabis vaping among middle and high school students.
Recent results from a national survey conducted by the University of Michigan reveal a sharp rise in cannabis vaping among middle and high school students.
Cannabis stocks were all the hype in late 2020 to early 2021, before fading away for years, but a similar, but smaller, rally seems to be starting up again.
Stay updated with the latest market activity on Tuesday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight.
NEUMÜNSTER, Germany, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Tilray Medical a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, transforming healthcare today announced the expansion of its Tilray Craft portfolio in Germany with five new cannabis flower products produced in Germany at Tilray’s EU‑GMP certified facility in Neumünster as part of the BfArM in‑country cultivation program. The additions reflect Tilray’s ongoing commitment to providing physicians and pharmacies with a diverse range of quality, EU‑GMP certified medical cannabis options for eligible patients.
